We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$3.18B
AUM Growth
-$2.44B
Cap. Flow
-$2.64B
Cap. Flow %
-83.08%
Top 10 Hldgs %
60.78%
Holding
672
New
112
Increased
61
Reduced
251
Closed
169

Sector Composition

Rank Sector Weight
1 Energy 29.51%
2 Technology 21.97%
3 Healthcare 10.49%
4 Real Estate 7.26%
5 Industrials 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REPL icon
276
Replimune Group
REPL
$1.02B
$843K 0.03%
+100,000
New +$1.16M
NET icon
277
Cloudflare
NET
$109B
$833K 0.03%
10,000
-35,000
-78% -$2.45M
SVRA icon
278
Savara
SVRA
$1.19B
$831K 0.03%
176,886
-203,466
-53% -$780K
BPMC
279
DELISTED
Blueprint Medicines
BPMC
$830K 0.03%
9,000
-39,984
-82% -$2.59M
CRC icon
280
California Resources
CRC
$4.65B
$827K 0.03%
15,119
-1,529
-9% -$80.4K
PRCT icon
281
Procept Biorobotics
PRCT
$1.18B
$826K 0.03%
19,717
-15,399
-44% -$524K
FRSH icon
282
Freshworks
FRSH
$3.25B
$822K 0.03%
+35,000
New +$693K
ADPT icon
283
Adaptive Biotechnologies
ADPT
$3.9B
$812K 0.03%
165,745
-35,595
-18% -$162K
AURA icon
284
Aura Biosciences
AURA
$805M
$797K 0.03%
90,000
+46,000
+105% +$390K
BDX icon
285
Becton Dickinson
BDX
$48.4B
$787K 0.02%
3,227
-10,044
-76% -$2.48M
ADBE icon
286
Adobe
ADBE
$106B
$766K 0.02%
1,284
DXCM icon
287
DexCom
DXCM
$31.7B
$766K 0.02%
6,172
-18,828
-75% -$1.92M
DYN icon
288
Dyne Therapeutics
DYN
$4.73B
$762K 0.02%
57,330
-53,422
-48% -$522K
LBPH
289
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$743K 0.02%
123,206
-139,059
-53% -$693K
DNLI icon
290
Denali Therapeutics
DNLI
$3.88B
$740K 0.02%
34,464
-24,488
-42% -$485K
UDR icon
291
UDR
UDR
$12.4B
$737K 0.02%
19,236
-56,206
-75% -$1.96M
SKIL icon
292
Skillsoft
SKIL
$76.9M
$733K 0.02%
+41,681
New +$729K
MTH icon
293
Meritage Homes
MTH
$4.79B
$731K 0.02%
+8,390
New +$578K
FCPT icon
294
Four Corners Property Trust
FCPT
$2.75B
$730K 0.02%
28,844
-14,416
-33% -$330K
ZTO icon
295
ZTO Express
ZTO
$17.9B
$716K 0.02%
33,650
+11,160
+50% +$253K
THRD
296
DELISTED
Third Harmonic Bio
THRD
$710K 0.02%
64,704
-60,296
-48% -$478K
NKTR icon
297
Nektar Therapeutics
NKTR
$2.51B
$707K 0.02%
83,383
-8,367
-9% -$63.4K
SPKLU
298
Spark I Acquisition Corp Unit
SPKLU
$702K 0.02%
+68,991
New +$700K
CPT icon
299
Camden Property Trust
CPT
$11.1B
$697K 0.02%
7,023
-18,909
-73% -$1.75M
KPTI icon
300
Karyopharm Therapeutics
KPTI
$45.3M
$694K 0.02%
53,488
-4,959
-8% -$66.8K

Similar funds

UBS O'Connor's Q4 2023 Portfolio in Review

As of Q4 2023, UBS O'Connor held 672 positions worth $3.18B, down 43% from $5.62B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

UBS O'Connor withdrew a net $2.64B in Q4 2023, closing 169 positions and reducing 251 holdings. Its most notable exit was Activision Blizzard, an estimated $1.06B position sold in full.

By sector, the portfolio is most concentrated in Energy at 30% of assets, up from 3.6% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Pioneer Natural Resource Co. worth $579M.

  • UBS O'Connor's largest Q4 2023 buy was Pioneer Natural Resource Co.: 2,576,808 shares worth $579M.
  • UBS O'Connor added most to Splunk Inc in Q4 2023, an estimated $446M increase.
  • UBS O'Connor's biggest Q4 2023 reduction was Capri Holdings, cutting an estimated $36.6M.
  • UBS O'Connor fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
  • UBS O'Connor's ten largest holdings make up 61% of its $3.18B portfolio in Q4 2023.
  • UBS O'Connor opened 112 new positions and closed 169 in Q4 2023.
  • UBS O'Connor's portfolio value fell 43% quarter-over-quarter to $3.18B.

Based on UBS O'Connor's 13F filing for Q4 2023, filed 14 Feb 2024.